SU6656

News alerts, weekly reports and conference planners

Company:

Hokkaido University, Pfizer

Drug class:

Aurora kinase inhibitor, SRC-family kinase (SFK) inhibitor

Related drugs:

BRAF mutation	Thyroid Gland Carcinoma	BRAF mutation	Thyroid Gland Carcinoma	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D	SU6656 Sensitive: D – Preclinical SU6656 Sensitive : D
RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	RET-PTC1 rearrangement	Thyroid Gland Papillary Carcinoma	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D	CI-1040 + SU6656 Sensitive: D – Preclinical CI-1040 + SU6656 Sensitive : D

Associations
(2)